JPS5716821A - Remedy for disease due to immunological dysfunction - Google Patents

Remedy for disease due to immunological dysfunction

Info

Publication number
JPS5716821A
JPS5716821A JP9214280A JP9214280A JPS5716821A JP S5716821 A JPS5716821 A JP S5716821A JP 9214280 A JP9214280 A JP 9214280A JP 9214280 A JP9214280 A JP 9214280A JP S5716821 A JPS5716821 A JP S5716821A
Authority
JP
Japan
Prior art keywords
remedy
immunological dysfunction
disease due
salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9214280A
Other languages
Japanese (ja)
Other versions
JPH0234923B2 (en
Inventor
Kazuhiro Goto
Michio Terasawa
Masao Kudome
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Priority to JP9214280A priority Critical patent/JPS5716821A/en
Publication of JPS5716821A publication Critical patent/JPS5716821A/en
Publication of JPH0234923B2 publication Critical patent/JPH0234923B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE: A medicine, containing a specific xanthone derivative as an active constituent, and effective for treating diseases due to the immunological dysfunction, e.g. cancer or rheumatism, with high safety.
CONSTITUTION: A medicine containing a compound of the formula (R is H or lower alkoxyl; A is O or sulfonyl) or a salt thereof as an active constituent. The compound of the formula or a salt thereof is formulated into a tablet, granule, injection or suppository and used as a remedy for diseases due to the immunological dysfunction. The dose thereof is usually about 3W1,000mg for an adult per day and administered in one or several fractions.
COPYRIGHT: (C)1982,JPO&Japio
JP9214280A 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction Granted JPS5716821A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9214280A JPS5716821A (en) 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9214280A JPS5716821A (en) 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction

Publications (2)

Publication Number Publication Date
JPS5716821A true JPS5716821A (en) 1982-01-28
JPH0234923B2 JPH0234923B2 (en) 1990-08-07

Family

ID=14046180

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9214280A Granted JPS5716821A (en) 1980-07-04 1980-07-04 Remedy for disease due to immunological dysfunction

Country Status (1)

Country Link
JP (1) JPS5716821A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4948657A (en) * 1972-05-19 1974-05-11

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4948657A (en) * 1972-05-19 1974-05-11

Also Published As

Publication number Publication date
JPH0234923B2 (en) 1990-08-07

Similar Documents

Publication Publication Date Title
ES8301632A1 (en) An orally administered drug form comprising a polar bioactive agent and an adjuvant.
DK160129C (en) PHARMACEUTICAL PREPARATION CONTAINING A GANGLIOSIDE COMPOUND, AN INTERNAL ESTER GANGLIOSIDE DERIVATIVE OR MIXTURES THEREOF
FR2363330A1 (en) MEDICINE INTENDED TO REDUCE FERTILITY IN MAMMALS
SE8500996D0 (en) METHOD OF TREATMENT
JPS5767516A (en) Novel analgesic agent
JPS5630917A (en) Preventive and remedy for hepatitis
JPS5781486A (en) Benzo(ij)quinolidine-2-carboxylic acid derivative
JPS57109721A (en) Carcinostatic agent
JPS5716821A (en) Remedy for disease due to immunological dysfunction
IE821258L (en) Anti-herpes medicaments
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
JPS56120683A (en) Piperazine derivative of theophylline* its manufacture and therapeutic composition for respiratory disease
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
FR2447368A1 (en) PHENYLETHYLAMINE DERIVATIVES, THEIR PREPARATION AND MEDICAMENT CONTAINING THESE SUBSTANCES
JPS56166115A (en) Carcinostatic agent
JPS5610174A (en) Analgesic and antiphlogistic agent
FR2472391B1 (en)
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS646214A (en) Remedy for ulcerative colonopathy
IT8349055A0 (en) B-OXO-L-CARBAMMOYL-PYRROLPROPIONITRILE, PROCEDURE FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, AS WELL AS THEIR THERAPEUTIC USE
JPS5742620A (en) Novel antiulcer agent
JPS56152418A (en) Hypoglycemic agent
JPS57126418A (en) Antiallergic agent
JPS57181012A (en) Drug composed of polyprenyl compound
JPS5569510A (en) Carcinostatic agent